Viewing Study NCT07203118


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:05 AM
Study NCT ID: NCT07203118
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2025-09-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B
Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module